Advances in gene therapy for mitochondrial genetic disorders: current status and clinical implementation challenges. [PDF]
Lyu L, Qie B, He Y, Chen F, Liu B.
europepmc +1 more source
Alpha-synuclein amyloids catalyze the degradation of ATP and other nucleotides. [PDF]
Castillo-Cáceres C +2 more
europepmc +1 more source
Amphioxus adenosine-to-inosine tRNA-editing enzyme that can perform C-to-U and A-to-I deamination of DNA. [PDF]
Gao Z +10 more
europepmc +1 more source
CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity. [PDF]
Rodriguez MM +16 more
europepmc +1 more source
Engineering of high-precision C-to-G base editors with expanded site selectivity and target compatibility. [PDF]
Li Z +10 more
europepmc +1 more source
Cytidine and dCMP Deaminases-Current Methods of Activity Analysis. [PDF]
Ligasová A +4 more
europepmc +1 more source
Anticancer Activity of Enantiomeric Neplanocins A: Exploring the Role of Chirality in Tumor Suppression. [PDF]
Pawlowska R +3 more
europepmc +1 more source
The AMP deaminase of the mollusk Helix pomatia is an unexpected member of the adenosine deaminase-related growth factor (ADGF) family. [PDF]
Tzertzinis G +6 more
europepmc +1 more source
A Review of Adenosine Deaminase 2 (ADA2) as a Biomarker of Monocyte/Macrophage Activation. [PDF]
Lim J +4 more
europepmc +1 more source
Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins. [PDF]
Han W +10 more
europepmc +1 more source

